Establishing a new alliance between partners with different cultures, norms, and ways of working is hard enough, but doing so when those partners work in multiple times zones and cannot meet in person creates a layer of complexity that can stretch alliance management to new levels of flexibility–and best practice.
Join the panel for a discussion that will examine best practices for sourcing, launching, and operationalizing a highly innovative partnership without ever meeting face to face.
Key discussion points will include:
Director of Alliance Management
As the Director of Alliance Management for Atara Biotherapeutics, Scott manages collaborations with leading academic research institutions and global industry partners. Atara's collaborations are focused on pioneering the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases through the use of Atara's allogeneic EBV T-cell platform. In this role, Scott focuses on embedding good partnering practices throughout each collaboration as well as driving alignment, timely decision-making, and clear strategic program planning. Scott brings more than 10 years of biotech experience managing collaborations across a range of therapeutic areas including oncology, respiratory, and bone health.
Prior to joining Atara, Scott held multiple roles at Amgen in Alliance Management, Business Development, and Finance. Scott holds a BA in Political Science from UCLA and an MBA from the UCLA Anderson School of Management and is CA-AM certified.